Avanafil API Market

The global Avanafil API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Avanafil acts by inhibiting a specific phosphodiesterase type 5 enzyme found in various body tissues, primarily in the corpus cavernosum penis. Other similar drugs are sildenafil, tadalafil and vardenafil. The advantage of avanafil is that it has very fast onset of action compared with other PDE5 inhibitors. It is absorbed quickly, reaching a maximum serum concentration in about thirty to forty-five minutes.[7] About two-thirds of the participants were able to engage in sexual activity within fifteen minutes.
Avanafil API Market aims to provide a comprehensive presentation of the global market for Avanafil API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avanafil API. Avanafil API Market contains market size and forecasts of Avanafil API in global, including the following market information:
Global Avanafil API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Avanafil API Market Sales, 2018-2023, 2024-2030, (Kg)
Global top five Avanafil API companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
99.0% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Avanafil API include Honour Lab Limited, Polpharma SA, Century Pharmaceuticals Ltd, Tosun United Pharma and Group, DEAFARMA, Hangzhou Longshine Bio-Tech CO., Ltd and Hangzhou think chemical Co.Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Avanafil API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• 99.0%
• 98.0%

• Tablets
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Avanafil API revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Avanafil API revenues share in global market, 2022 (%)
• Key companies Avanafil API sales in global market, 2018-2023 (Estimated), (Kg)
• Key companies Avanafil API sales share in global market, 2022 (%)

• Honour Lab Limited
• Polpharma SA
• Century Pharmaceuticals Ltd
• Tosun United Pharma and Group
• DEAFARMA
• Hangzhou Longshine Bio-Tech CO., Ltd
• Hangzhou think chemical Co.Ltd.

Outline of Major Chapters:
Chapter 1: Introduces the definition of Avanafil API, market overview.
Chapter 2: Global Avanafil API market size in revenue and volume.
Chapter 3: Detailed analysis of Avanafil API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Avanafil API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Avanafil API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.